Funding for this research was provided by:
Received: 2 September 2022
Accepted: 10 November 2022
First Online: 5 December 2022
: This study was approved by the Sterling IRB, Protocol #C4591034. Participation in the study was voluntary and anonymous. Consent was obtained electronically via the CVS Health E-Consent platform. Participants were informed of their right to refuse or withdraw from the study at any time. Participants were compensated for their time.
: All authors have given their approval for this manuscript version to be published.
: MDF, MMM, JMZ, LP, MBA and JCC are employees of Pfizer and may hold stock or stock options of Pfizer. XS and HC are employees of CVS Health and may hold stock of CVS health. YPT was employee of CVS Health when current study was conducted.